About Servier Pharmaceuticals
Servier Pharmaceuticals is a company based in Boston (United States) founded in 1954. It operates as a B2B. Servier Pharmaceuticals offers products and services including Oncology Therapeutics and Neurology Drugs. Servier Pharmaceuticals operates in a competitive market with competitors including Adicet Bio, Orca Bio, Ossium Health, Auron Therapeutics and Nordic Nanovector, among others.
- Headquarter Boston, United States
- SectorsHealthcare
- Email••••••••
- Website servier.us
- Social LinkedIn X YouTube
- Legal Name Servier Pharmaceuticals Llc
Products & Services of Servier Pharmaceuticals
Servier Pharmaceuticals offers a comprehensive portfolio of products and services, including Oncology Therapeutics and Neurology Drugs.
Medications targeting cancers and rare diseases
Treatments for neurological disorders and unmet needs
Apps and channels of Servier Pharmaceuticals
its YouTube channel Servier Pharmaceuticals has 121 subscribers and 11 videos.
Videos from Servier Pharmaceuticals
The most watched videos on Servier Pharmaceuticals's YouTube channel, Servier Pharmaceuticals (121 subscribers). Click a video to play it here.
More on Servier Pharmaceuticals.
People of Servier Pharmaceuticals
74 people are tracked at Servier Pharmaceuticals (35 in leadership, 39 in team).
| Name | Role | Group |
|---|---|---|
Deniz Razon | Chief Business Officer | Leadership |
Kimberly Sandru | Regional Sales Director | Leadership |
Rory Murphy | Chief of Staff | Leadership |
Nick Stefos | Head, Human Ressources | Leadership |
Dalia Mahmoud | Regional Medical Affairs Director | Leadership |
Danielle Button | Head, Finance | Leadership |
Arjun Prasad | Head, Sales & Marketing | Leadership |
Kelly Schelmm | Head, Communications & Public Affairs | Leadership |
Dianna Deconciliis | Associate Director, Talent Acquisition | Leadership |
Mina Younan | General Manager | Leadership |
Ken Warren | National Sales Director, Hematology | Leadership |
Kristina Morrisseau | Sr. Director, Total Rewards & HR Operations | Leadership |
Michael Schneller | Director Of Talent Acquisition | Leadership |
Samantha Small | Head Of Corporate Strategy And Operations | Leadership |
Jefferson Simmons | Head, National Accounts | Leadership |
David K. Lee | CEO | Leadership |
Pedro Crisanto | COO, R&D | Leadership |
Rabecka Martin | Head, Medical | Leadership |
Nate Dahl | Head Of Patient Affairs (interim) | Leadership |
Laurel Glover | Commercial Recruitment Partner (through Gqr) | Leadership |
54 more people are available in the full profile.
Complete people profiles for Servier Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Servier Pharmaceuticals
Servier Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adicet Bio, Orca Bio, Ossium Health, Auron Therapeutics and Nordic Nanovector, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| adicetbio.com | 2014 | Menlo Park, United States | $51M | 86 | Immune cell therapies for cancer treatment are developed. | |
| orcabio.com | 2016 | Menlo Park, United States | $192M | 66 | Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | |
| ossiumhealth.com | 2016 | San Francisco, United States | $125.41M | – | Ossium Health is focused on bioengineering for improved health. | |
| aurontx.com | 2018 | Wellesley, United States | $103.84M | – | Developer of cancer therapeutics for the treatment of blood cancer | |
| nordicnanovector.com | 2009 | Oslo, Norway | $51.69M | 40 | Antibody radionuclide conjugates are developed for haematological cancers. | |
| allterum.com | 2018 | Houston, United States | $65.8M | – | Monoclonal antibody therapies for pediatric leukemia are developed. | |
| kiadis.com | 1997 | Amsterdam, Netherlands | $32.95M | – | Therapeutic solutions for hematopoietic stem cell transplants are developed. | |
| priothera.com | 2020 | Dublin, Ireland | $35.47M | – | Therapeutics for hematological malignancies are developed by Priothera. |
Detailed competitors of Servier Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Servier Pharmaceuticals
Websites that share an audience with Servier Pharmaceuticals (servier.us).
Websites whose visitors overlap most with Servier Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pieris.com | 100% | – | – | View details | |
| praxismedicines.com | 100% | 35.6K | #1,244,570 | View details | |
| ensoma.com | 100% | 2.8K | #4,644,561 | View details | |
| amylyx.com | 100% | 14.1K | #1,731,185 | View details | |
| zealandpharma.com | 100% | 25.2K | #1,273,571 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Servier Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Servier Pharmaceuticals
Complete news archive for Servier Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Servier Pharmaceuticals
10 companies that operate in the same segment as Servier Pharmaceuticals (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Servier Pharmaceuticals
Servier Pharmaceuticals was founded in 1954.
Servier Pharmaceuticals is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Servier is a global pharmaceutical leader specializing in oncology and neurology, addressing rare diseases and unmet patient needs. The company advances therapeutics via a robust RD pipeline, clinical trials, and strategic partnerships. Based in Boston, MA, USA, Servier delivers innovative medicines to healthcare providers and patients worldwide, emphasizing patient-centered care and scientific excellence.
Servier Pharmaceuticals's top competitors include Orca Bio, Ossium Health and Adicet Bio.
Servier Pharmaceuticals offers Oncology Therapeutics and Neurology Drugs.
Servier Pharmaceuticals operates through Servier Pharmaceuticals Llc.